TY - JOUR
AU - Amid Shakeri
AU - Ying Wang
AU - Yimu Zhao
AU - Shira Landau
AU - Kevin Perera
AU - Jonguk Lee
AU - Milica Radisic
AB - Vascular diseases, such as atherosclerosis and thrombosis, are major causes of morbidity and mortality worldwide. Traditional in vitro models for studying vascular diseases have limitations, as they do not fully recapitulate the complexity of the in vivo microenvironment. Organ-on-a-chip systems have emerged as a promising approach for modeling vascular diseases by incorporating multiple cell types, mechanical and biochemical cues, and fluid flow in a microscale platform. This review provides an overview of recent advancements in engineering organ-on-a-chip systems for modeling vascular diseases, including the use of microfluidic channels, ECM (extracellular matrix) scaffolds, and patient-specific cells. We also discuss the limitations and future perspectives of organ-on-a-chip for modeling vascular diseases.
BT - Arteriosclerosis, Thrombosis, and Vascular Biology
DA - 2023-12
DO - 10.1161/ATVBAHA.123.318233
IS - 12
N2 - Vascular diseases, such as atherosclerosis and thrombosis, are major causes of morbidity and mortality worldwide. Traditional in vitro models for studying vascular diseases have limitations, as they do not fully recapitulate the complexity of the in vivo microenvironment. Organ-on-a-chip systems have emerged as a promising approach for modeling vascular diseases by incorporating multiple cell types, mechanical and biochemical cues, and fluid flow in a microscale platform. This review provides an overview of recent advancements in engineering organ-on-a-chip systems for modeling vascular diseases, including the use of microfluidic channels, ECM (extracellular matrix) scaffolds, and patient-specific cells. We also discuss the limitations and future perspectives of organ-on-a-chip for modeling vascular diseases.
PY - 2023
SP - 2241
EP - 2255
T2 - Arteriosclerosis, Thrombosis, and Vascular Biology
TI - Engineering Organ-on-a-Chip Systems for Vascular Diseases
UR - https://www.ahajournals.org/doi/10.1161/ATVBAHA.123.318233
VL - 43
Y2 - 2024-08-13
ER -